繁體中文
返回
- English
- 繁體中文
- 简体中文
- 深色
- 淺色
Safety Shot | CORRESP: CORRESP
Safety Shot | CORRESP: CORRESP
Safety Shot | CORRESP:信函
牛牛AI助理已提取核心訊息
Safety Shot, Inc. has addressed several comments from the Securities and Exchange Commission (SEC) regarding its Post-Effective Amendment No. 3 on Form S-1, initially filed on December 27, 2023. The company clarified discrepancies in its product launch disclosures, stating that Safety Shot was launched on Amazon and its website in December 2023, with plans to expand to big box stores in the first quarter of 2024. Safety Shot also revised its Registration Statement to remove highlighted license agreements from the summary, instead detailing them in the Business section, and filed the agreements as exhibits. The company responded to the SEC's concerns about its ability to continue as a going concern by disclosing its primary capital requirements and potential sources of capital, including equity...Show More
Safety Shot, Inc. has addressed several comments from the Securities and Exchange Commission (SEC) regarding its Post-Effective Amendment No. 3 on Form S-1, initially filed on December 27, 2023. The company clarified discrepancies in its product launch disclosures, stating that Safety Shot was launched on Amazon and its website in December 2023, with plans to expand to big box stores in the first quarter of 2024. Safety Shot also revised its Registration Statement to remove highlighted license agreements from the summary, instead detailing them in the Business section, and filed the agreements as exhibits. The company responded to the SEC's concerns about its ability to continue as a going concern by disclosing its primary capital requirements and potential sources of capital, including equity or debt sales, warrant exercises, and sales of shares from other investments. Safety Shot updated its executive and director compensation disclosures and removed all incorporation by reference in its Registration Statement. The company also clarified the roles of its eight full-time employees and revised its product development and commercialization disclosures, ensuring compliance with FDA regulations and removing any unapproved claims of safety and efficacy. The revised Registration Statement includes clarifications on the regulatory status of its products, including Safety Shot's classification as a dietary supplement and its compliance with California Proposition 65.
Safety Shot, Inc.已經回應了美國證券交易委員會(SEC)關於其最初於2023年12月27日提交的S-1表格生效後第3號修正案的幾條評論。該公司澄清了其產品發佈披露中的差異,稱Safety Shot於2023年12月在亞馬遜及其網站上推出,並計劃在2024年第一季度擴展到大型門店。Safety Shot還修訂了其註冊聲明,將重點許可協議從摘要中刪除,改爲在 “業務” 部分對其進行詳細說明,並將協議作爲證物提交。該公司對美國證券交易委員會對其持續經營能力的擔憂做出了回應,披露了其主要資本要求和潛在資本來源,包括股權或債務出售、認股權證行使以及出售其他投資的股票。Safety Sho...展開全部
Safety Shot, Inc.已經回應了美國證券交易委員會(SEC)關於其最初於2023年12月27日提交的S-1表格生效後第3號修正案的幾條評論。該公司澄清了其產品發佈披露中的差異,稱Safety Shot於2023年12月在亞馬遜及其網站上推出,並計劃在2024年第一季度擴展到大型門店。Safety Shot還修訂了其註冊聲明,將重點許可協議從摘要中刪除,改爲在 “業務” 部分對其進行詳細說明,並將協議作爲證物提交。該公司對美國證券交易委員會對其持續經營能力的擔憂做出了回應,披露了其主要資本要求和潛在資本來源,包括股權或債務出售、認股權證行使以及出售其他投資的股票。Safety Shot更新了其高管和董事薪酬披露,並刪除了其註冊聲明中所有以引用方式註冊的內容。該公司還澄清了其八名全職員工的職責,並修改了其產品開發和商業化披露,確保遵守美國食品和藥物管理局的法規,並刪除了任何未經批准的安全性和有效性聲明。修訂後的註冊聲明包括對其產品的監管狀況的澄清,包括Safety Shot被歸類爲膳食補充劑及其對加州65提案的遵守情況。
有用
沒用
該公告為獨立文件:
譯文內容由第三人軟體翻譯。
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
資訊熱榜
更新時間